Phase I study of erlotinib and hydroxychloroquine in non-small cell lung cancer

被引：0
|
作者：
Sequist, Lecia, V [1 ]
Sharma, Sreenath, V [1 ]
Supko, Jeffrey G. [1 ]
Neal, Joel W. [1 ]
Fidias, Panos [1 ]
Temel, Jennifer [1 ]
Heist, Suk Rebecca [1 ]
Shaw, Alice T. [1 ]
Engelman, Jeffrey A. [1 ]
Settleman, Jeffrey E. [1 ]
Lynch, Thomas J. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S712 / S713
页数：2
相关论文
共 50 条
  • [41] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [42] Erlotinib for the treatment of brain metastases in non-small cell lung cancer
    Brower, Jeffrey V.
    Robins, H. Ian
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 1013 - 1021
  • [43] PHASE II TRIAL OF ERLOTINIB IN PREVIOUSLY TREATED PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Okano, Yoshio
    Shinohara, Tsutomu
    Machida, Hisanori
    Hatakeyama, Nobuo
    Takeuchi, Eiji
    Doi, Hiroyuki
    Kubota, Tetsuya
    Yokoyama, Akihito
    Ogushi, Fumitaka
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1175 - S1176
  • [44] MicroRNA markers for erlotinib resistance in non-small cell lung cancer
    Nelson, Kristen
    Ranade, Aarati
    Kashey, Trevor
    Kingsley, Chris
    Weiss, Glen
    CANCER RESEARCH, 2009, 69
  • [45] Cutaneous complications of erlotinib in the treatment of non-small cell lung cancer
    Preda, V.
    Mann, S.
    Lee, S.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2008, 16 (03): : 133 - 141
  • [46] Use review of Erlotinib in advanced non-small cell lung cancer
    Alvarez-Payero, M.
    Ucha-Samartin, M.
    Martinez-Lopez-de-Castro, N.
    Campelo-Sanchez, E.
    Alvarez-Seoane, J.
    Vazquez-Lopez, C.
    Inaraja-Bobo, M. T.
    Perez Parente, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 438 - 438
  • [47] Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
    Li, Tianhong
    Lara, Primo N., Jr.
    Mack, Philip C.
    Perez-Soler, Roman
    Gandara, David R.
    CURRENT DRUG TARGETS, 2010, 11 (01) : 85 - 94
  • [48] Review of erlotinib in the treatment of advanced non-small cell lung cancer
    Ganjoo, Kristen N.
    Wakelee, Heather
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 335 - 346
  • [49] Erlotinib: a new therapeutic approach for non-small cell lung cancer
    Bonomi, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (08) : 1395 - 1401
  • [50] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
12345